Signaturefd, LLC Iovance Biotherapeutics, Inc. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 8,698 shares of IOVA stock, worth $49,056. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,698

Previous 9,220 5.66%

Holding current value

$49,056

Previous $73,000 10.96%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$7.28 - $11.9 $3,800 - $6,211	-522 Reduced 5.66%	8,698 $81,000
Q2 2024 Jul 29, 2024	SELL	$7.78 - $14.19 $1,237 - $2,256	-159 Reduced 1.7%	9,220 $73,000
Q1 2024 May 03, 2024	BUY	$7.59 - $17.47 $4,979 - $11,460	656 Added 7.52%	9,379 $138,000
Q4 2023 Jan 31, 2024	BUY	$3.3 - $8.89 $20,714 - $55,802	6,277 Added 256.62%	8,723 $70,000
Q3 2023 Nov 03, 2023	BUY	$4.44 - $8.79 $6,566 - $13,000	1,479 Added 152.95%	2,446 $11,000
Q2 2023 Aug 01, 2023	BUY	$5.36 - $9.06 $3,650 - $6,169	681 Added 238.11%	967 $6,000
Q1 2023 Apr 28, 2023	BUY	$5.53 - $8.22 $1,581 - $2,350	286 New	286 $1,000
Q2 2022 Aug 10, 2022	SELL	$6.38 - $18.33 $5,078 - $14,590	-796 Reduced 93.98%	51 $1,000
Q1 2022 May 02, 2022	BUY	$12.38 - $19.1 $2,810 - $4,335	227 Added 36.61%	847 $14,000
Q4 2021 Jan 25, 2022	BUY	$16.55 - $27.63 $513 - $856	31 Added 5.26%	620 $12,000
Q3 2021 Oct 28, 2021	BUY	$20.35 - $26.63 $5,555 - $7,269	273 Added 86.39%	589 $15,000
Q2 2021 Jul 26, 2021	BUY	$16.33 - $33.07 $3,151 - $6,382	193 Added 156.91%	316 $8,000
Q1 2021 Apr 30, 2021	BUY	$28.67 - $52.59 $3,526 - $6,468	123 New	123 $4,000
Q3 2020 Nov 03, 2020	SELL	$27.75 - $36.3 $1,359 - $1,778	-49 Closed	0 $0
Q2 2020 Jul 30, 2020	BUY	$27.21 - $41.0 $1,333 - $2,009	49 New	49 $1,000

Others Institutions Holding IOVA

# of Institutions

319

Shares Held

243M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $890M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account